Seminars in Thoracic and Cardiovascular Surgery: Pediatric Cardiac Surgery Annual
Volume 3, Issue 1, January 2000, Pages 63-81
Clinical SciencePathobiology of pulmonary hypertension: Impact on clinical management☆
References (87)
- et al.
Atrial natriuretic peptide and nitric oxide in children with pulmonary hypertension after surgical repair of congenital heart disease
Am J Cardiol
(1996) - et al.
Clinical applications of inhaled nitric oxide in children with pulmonary hypertension
Adv Pharmacol
(1995) - et al.
Pulmonary vascular disease in complete transposition of the great arteries: A study of 200 patients
Am J Cardiol
(1974) - et al.
The diagnosis of progressive pulmonary vascular disease in children with ventricular septal defects
J Pediatr
(1966) - et al.
Pulmonary vascular disease in complete artioventricular canal defect
Am J Cardiol
(1977) - et al.
Down's Syndrome, complete atrioventricular canal and pulmonary vascular obstructive disease
J Thorac Cardiovasc Surg
(1990) - et al.
Lung biopsy with frozen section as a diagnostic aid in patients with congenital heart defects
Am J Cardiol
(1981) - et al.
Abnormalities in von Willebrand factor and antithrombin III after cardiopulmonary bypass operations for congenital heart disease
Thorac Cardiovasc Surg
(1992) - et al.
Effect of ambient oxygen changes on platelet activating factor production by fetal ovine endothelial cells
Prostaglandins
(1991) - et al.
Plasma endothelin levels and surgically correctable pulmonary hypertension
Ann Thorac Surg
(1993)
Fibronectin, hyaluronan and a hyaluronan binding protein contribute to increased ductus arteriosus smooth muscle cell migration
Dev Biol
(1991)
Aortopulmonary shunts in growing pigs
J Thorac Cardiovasc Surg
(1979)
Chronic pulmonary hypertension in sheep: Temporal progression of lesions
J Surg Res
(1996)
Human mast cell chymase and leukocyte elastase release latent transforming growth factor-β1 from the extracellular matrix of cultured human epithelial and endothelial cells
J Biol Chem
(1995)
Regulation of astrocytic tenascin by basic fibroblast growth factor
Dev Biol
(1993)
Functional interplay between interleukin-1 receptor and elastin binding protein regulates fibronectin production in coronary artery smooth muscle cells
Exp Cell Res
(1996)
Lung biopsy in congenital heart disease: A morphometric approach to pulmonary vascular disease
Circulation
(1978)
Ultrastructural findings in lung biopsy material from children with congenital heart defects
Am J Pathol
(1980)
Vascular structure in lung tissue obtained at biopsy correlated with pulmonary hemodynamic findings after repair of congenital heart defects
Circulation
(1984)
Blunting of stressing responses of the pulmonary circulation of infants by fentanyl
Anesth Analg
(1985)
Modification of pulmonary hypertension secondary to congenital heart disease with prostacyclin therapy
Am Rev Resp Dis
(1987)
Profile of paediatric patients with pulmonary hypertension judged by responsiveness to vasodilators
Br Heart J
(1993)
The spectrum of pulmonary vascular disease in transposition of the great arteries
Circulation
(1969)
Transposition of the great arteries with intact ventricular septum and patent ductus arteriosus
Am J Cardiol
(1977)
The development of pulmonary vascular obstructive disease after successful Mustard operation in early infancy
Circulation
(1978)
Quantitative analysis of the pulmonary wedge angiogram in congenital heart defects: Correlation with hemodynamic data and morphometric findings in lung biopsy tissue
Circulation
(1981)
Pulmonary vascular structure in patients dying after a Fontan procedure: The lung as a risk factor
Br Heart J
(1984)
Pulmonary artery endothelial abnormalities in patients with congenital heart defects and pulmonary hypertension: A correlation of light with scanning electron microscopy and transmission electron microscopy
Lab Invest
(1986)
Abnormal endothelial factor VIII associated with pulmonary hypertension and congenital heart defects
Circulation
(1987)
Plasma thromboxane B2 concentration in pulmonary hypertension associated with congenital heart disease
Circulation
(1994)
Pulmonary neuroendocrine cells in normal human lung and in pulmonary hypertension
Lab Invest
(1986)
A study of nerves containing peptides in the pulmonary vasculature of healthy infants and children and of those with pulmonary hypertension
Br Heart J
(1989)
Oxygen sensing in airway chemoreceptors
Nature
(1993)
Increased respiratory system resistance in bronchial smooth muscle hypertrophy in children with acute postoperative pulmonary hypertension
Am J Respir Crit Care Med
(1995)
Impairment of pulmonary endothelium-dependent relaxation in patients with Eisenmenger's syndrome
Br J Pharmacol
(1990)
Circulating endothelin levels in children with congenital heart disease
Br Heart J
(1993)
Impairment of endothelium-dependent pulmonary artery relaxation in children with congenital heart disease and abnormal pulmonary hemodynamics
Circulation
(1993)
Plasma endothelin concentrations in patients with pulmonary hypertension associated with congenital heart defects. Evidence for increased production of endothelin in pulmonary circulation
Circulation
(1991)
Induction of tenascin and fibronectin are features associated with increased smooth muscle cell proliferation during the development of progressive pulmonary hypertension in children
Am J Pathol
(1997)
Regulation of tenascin-C, a vascular smooth muscle cell survival factor that interacts with the avβ3 integrin to promote epidermal growth factor receptor phosphorylation and growth
J Cell Biol
(1997)
Tenascin-C is induced with progressive pulmonary vascular disease in rats is functionally related to increased smooth muscle cell proliferation
Circ Res
(1996)
Upregulation of fibronectin synthesis by interleukin-1β in coronary artery smooth muscle cells is associated with the development of the post-cardiac transplant arteriopathy in piglets
J Clin Invest
(1992)
Vascular remodeling in primary pulmonary hypertension. Potential role for transforming growth factor-β
Am J Pathol
(1994)
Cited by (0)
- ☆
Address reprint requests to Marlene Rabinovitch, MD, Director, Division of Cardiovascular Research, The Hospital for Sick Children, 555 University Ave, Toronto, Ontario, Canada M5G 1X8.
Copyright © 2000 W.B. Saunders Company. All rights reserved.